Chitosan–Prussian blue nanoparticles for ROS scavenging and diabetes therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Pancreatic function and diabetes · Natural Antidiabetic Agents Studies · Diabetes and associated disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (15)
Show source-provided references
1. Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications10.3390/ijms26031094 ↗
2. Oxidative stress: the vulnerable beta-cell10.1042/BST0360343 ↗
3. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity10.1016/j.cmet.2013.05.001 ↗
4. Nanozymes as emerging catalytic therapeutics for the intervention of metabolic diseases10.1016/j.preme.2025.100042 ↗
5. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers10.1021/jacs.5b12070 ↗
6. Uncovering the fate and risks of intravenously injected Prussian blue nanoparticles in mice by an integrated methodology of toxicology, pharmacokinetics, proteomics, and metabolomics10.1186/s12989-023-00529-7 ↗
7. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy10.1016/j.biomaterials.2007.12.038 ↗
8. Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats10.1021/jf100662r ↗
9. Preparation and characteristics evaluation of chitosan-coated nanoliposomes containing ferrous sulfate10.1038/s41598-025-03832-9 ↗
10. Prussian blue nanozymes: progress, challenges, and opportunities10.1039/D3NR01741A ↗
11. Toxicity of cerium oxide nanoparticles in human lung cancer cells10.1080/10915810600959543 ↗
12. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways10.1016/j.neulet.2014.10.016 ↗
13. Prussian blue nanoparticles mitigate inflammatory osteolysis by reducing oxidative stress and enhancing endogenous antioxidant systems10.1016/j.colsurfb.2025.114806 ↗
14. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes10.1111/dom.12971 ↗
15. A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense10.4093/dmj.2013.37.2.106 ↗